Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The patent, issued in 1986, described “a dispenser suitable for use in dispensing a liquid medicine, for instance insulin solution. The dispenser is, in principle, constructed as a hypodermic syringe ...

NovoLog (insulin aspart) is a fast-acting insulin used for diabetes treatment. It’s injected 5 to 10 minutes before meals. It may be prescribed with other insulins or oral diabetes drugs. NovoLog ...

If you rely on insulin to manage your diabetes, you already know how essential delivery tools like insulin pens are for day-to-day treatment. One popular option is the NovoPen 4, a reusable insulin ...

(Reuters) -Ozempic-maker Novo Nordisk (NYSE:NVO) on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market ...

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 showing an overall mean absolute relative difference (MARD) of 8.0%, making it ...

The Disposable Insulin-Delivery Device Market is experiencing a significant surge, fueled by the rising prevalence of diabetes worldwide. According to industry estimates, the market value reached ...

The global smart insulin pens market is anticipated to grow significantly, with its size projected to increase from USD 111.2 million in 2022 to USD 350.6 million by 2032, reflecting a compound annual ...